- CA$19.86m
- CA$19.70m
- CA$0.10m
Annual balance sheet for Diagnos, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.36 | 0.921 | 0.297 | 0.219 | 3.24 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.204 | 0.345 | 0.263 | 0.167 | 0.17 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1.59 | 1.29 | 0.575 | 0.407 | 3.47 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.328 | 0.253 | 0.248 | 0.257 | 0.17 |
| Long Term Investments | |||||
| Total Assets | 1.95 | 1.54 | 0.823 | 0.664 | 3.64 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.55 | 0.659 | 0.719 | 1.62 | 3.12 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.818 | 1.66 | 2.77 | 3.72 | 3.4 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1.13 | -0.114 | -1.95 | -3.05 | 0.233 |
| Total Liabilities & Shareholders' Equity | 1.95 | 1.54 | 0.823 | 0.664 | 3.64 |
| Total Common Shares Outstanding |